All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Aytu Bioscience Inc., of Englewood, Colo. said clinical data for Natesto (testosterone), a nasal gel approved as a replacement therapy for men diagnosed with hypogonadism, has shown that the pharmacokinetics, safety and efficacy of Natesto for restoring normal testosterone levels in men with low testosterone levels is not adversely affected by seasonal allergies.